GCP
BCDA icon

GSA Capital Partners’s BioCardia BCDA Stock Holding History

GSA Capital Partners’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+12,862
New +$13.6K ﹤0.01% 1685
2026
Q1 		– Sell
-11,303
Closed -$14K – 1721
2025
Q4 		$14K Buy
+11,303
New +$15.4K ﹤0.01% 1610

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

GSA Capital Partners's BCDA Position: Q2 2026 in Review

GSA Capital Partners opened a new position in BioCardia (BCDA) in Q2 2026: 12,862 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #1685 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in BCDA as recently as Q4 2025.

GSA Capital Partners first reported a position in BCDA in Q4 2025 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • GSA Capital Partners held 12,862 shares of BioCardia worth $16K as of Q2 2026.
  • BioCardia was a new GSA Capital Partners position in Q2 2026.
  • BioCardia made up ﹤0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1685 holding.
  • GSA Capital Partners first reported a position in BioCardia in Q4 2025 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.